Alpa Laboratorie

{
  "main_header": {
    "sid": 476646,
    "name": "Alpa Laboratorie",
    "stock_name": "Alpa Laboratorie",
    "full_name": "Alpa Laboratories Ltd",
    "name_url": "stocks-analysis/alpa-laboratorie",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "72.05",
    "chg": -2.13,
    "chgp": "-2.87%",
    "dir": -1,
    "prev_price": "74.18",
    "mcapval": "158.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532878,
    "symbol": "ALPA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE385I01010",
    "curr_date": "Feb 11",
    "curr_time": "",
    "bse_nse_vol": "28.13 k",
    "exc_status": "Active",
    "traded_date": "Feb 11, 2026",
    "traded_date_str": "2026 02 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alpa-laboratorie-476646-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Alpa Laboratories Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-alpa-laboratories-ltd-latest-results-good-or-bad-3833411",
        "imagepath": "",
        "date": "2026-02-11 19:32:32",
        "description": "Alpa Laboratories Ltd's latest financial results for Q3 FY26 present a mixed operational picture. The company reported a revenue of ₹29.05 crores, reflecting an 11.09% year-on-year growth, which indicates some ability to maintain top-line momentum in a challenging market. Sequentially, revenue also grew by 10.62% from the previous quarter, suggesting improving demand conditions.\n\nHowever, the net profit for the same quarter was ₹1.90 crores, which represents a significant decline of 78.65% year-on-year. This sharp drop raises concerns about the company's profitability and overall financial health. The operating margin, excluding other income, stood at 5.23%, which is an improvement from the previous quarter's negative margin but still indicates volatility in operational performance. The reliance on other income to support profitability is notable, with a substantial portion of operating profit being derived..."
      },
      {
        "title": "Alpa Laboratories Q3 FY26: Profit Recovery Masks Deeper Operational Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/alpa-laboratories-q3-fy26-profit-recovery-masks-deeper-operational-concerns-3833123",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AlpaLaboratorie_quaterlyResult_3833123.png",
        "date": "2026-02-11 15:18:03",
        "description": "Alpa Laboratories Ltd., the Indore-based pharmaceutical formulations manufacturer, reported a sequential profit recovery in Q3 FY26 with net profit of ₹1.90 crores, marking a dramatic 1,627.27% quarter-on-quarter surge from the near-zero ₹0.11 crores in Q2 FY26. However, the year-on-year comparison reveals a concerning 78.65% decline from ₹8.90 crores in Q3 FY24, underscoring persistent operational challenges that have plagued the micro-cap pharmaceutical company throughout FY26."
      },
      {
        "title": "Alpa Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alpa-laboratories-ltd-is-rated-strong-sell-3827280",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AlpaLaboratorie_mojoScore_3827280.png",
        "date": "2026-02-08 10:10:17",
        "description": "Alpa Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 08 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "When is the next results date for Alpa Laboratories Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-alpa-laboratories-ltd-3812075",
        "imagepath": "",
        "date": "2026-01-30 23:20:17",
        "description": "The next results date for Alpa Laboratories Ltd is scheduled for 11 February 2026...."
      },
      {
        "title": "Alpa Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alpa-laboratories-ltd-is-rated-strong-sell-3807392",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AlpaLaboratorie_mojoScore_3807392.png",
        "date": "2026-01-28 10:10:20",
        "description": "Alpa Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 28 January 2026, providing investors with an up-to-date view of its performance and outlook."
      },
      {
        "title": "Alpa Laboratories Ltd Falls to 52-Week Low of Rs.63.76 Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alpa-laboratories-ltd-falls-to-52-week-low-of-rs6376-amid-continued-downtrend-3798537",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AlpaLaboratorie_priceRelatedfactors_3798537.png",
        "date": "2026-01-21 11:29:21",
        "description": "Alpa Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a fresh 52-week low of Rs.63.76, marking a significant decline amid broader market pressures and company-specific performance issues."
      },
      {
        "title": "Alpa Laboratories Ltd Falls to 52-Week Low of Rs.67.83",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alpa-laboratories-ltd-falls-to-52-week-low-of-rs6783-3796388",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AlpaLaboratorie_priceRelatedfactors_3796388.png",
        "date": "2026-01-20 11:39:11",
        "description": "Alpa Laboratories Ltd has declined to a fresh 52-week low of Rs.67.83, marking a significant downturn amid broader market fluctuations and company-specific performance issues. The stock’s recent slide reflects ongoing pressures in the Pharmaceuticals & Biotechnology sector, with the share price now trading well below all key moving averages."
      },
      {
        "title": "Alpa Laboratories Ltd Falls to 52-Week Low of Rs.68.16 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alpa-laboratories-ltd-falls-to-52-week-low-of-rs6816-amidst-continued-downtrend-3794620",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AlpaLaboratorie_priceRelatedfactors_3794620.png",
        "date": "2026-01-19 12:41:42",
        "description": "Alpa Laboratories Ltd’s stock declined sharply to a fresh 52-week low of Rs.68.16 on 19 Jan 2026, marking a significant drop amid ongoing challenges in both its long-term and recent financial performance. The stock’s fall comes despite a broadly stable market environment, with the Sensex closing down 0.66% but still near its 52-week high."
      },
      {
        "title": "Alpa Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alpa-laboratories-ltd-is-rated-strong-sell-3781658",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AlpaLaboratorie_mojoScore_3781658.png",
        "date": "2026-01-05 10:11:38",
        "description": "Alpa Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 05 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      }
    ],
    "total": 95,
    "sid": "476646",
    "stock_news_url": "https://www.marketsmojo.com/news/alpa-laboratories-476646"
  },
  "announcements": [
    {
      "details": "Alpa Laboratories Limited has informed the Exchange regarding 'Disclosure under Regulation 23(9) of SEBI (LODR) 2015 for the period ended 30th September, 2019.'.",
      "source": "NSE",
      "caption": "Alpa Laboratories Limited - Updates",
      "datetime": "05-Dec-2019"
    },
    {
      "details": "Alpa Laboratories Limiteds Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Alpa Laboratories Limited - Clarification - Financial Results",
      "datetime": "14-Nov-2019"
    },
    {
      "details": " <table><tr><td>The Exchange had sought clarification from Alpa Laboratories Limited for the quarter ended 30-Jun-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is enclosed. </td></tr></table>",
      "source": "NSE",
      "caption": "Reply to Clarification- Financial results",
      "datetime": "12-Sep-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Are Alpa Laboratories Ltd latest results good or bad?

2026-02-11 19:32:32

Alpa Laboratories Ltd's latest financial results for Q3 FY26 present a mixed operational picture. The company reported a revenue of ₹29.05 crores, reflecting an 11.09% year-on-year growth, which indicates some ability to maintain top-line momentum in a challenging market. Sequentially, revenue also grew by 10.62% from the previous quarter, suggesting improving demand conditions. However, the net profit for the same quarter was ₹1.90 crores, which represents a significant decline of 78.65% year-on-year. This sharp drop raises concerns about the company's profitability and overall financial health. The operating margin, excluding other income, stood at 5.23%, which is an improvement from the previous quarter's negative margin but still indicates volatility in operational performance. The reliance on other income to support profitability is notable, with a substantial portion of operating profit being derived...

Read full news article

Alpa Laboratories Q3 FY26: Profit Recovery Masks Deeper Operational Concerns

2026-02-11 15:18:03

Alpa Laboratories Ltd., the Indore-based pharmaceutical formulations manufacturer, reported a sequential profit recovery in Q3 FY26 with net profit of ₹1.90 crores, marking a dramatic 1,627.27% quarter-on-quarter surge from the near-zero ₹0.11 crores in Q2 FY26. However, the year-on-year comparison reveals a concerning 78.65% decline from ₹8.90 crores in Q3 FY24, underscoring persistent operational challenges that have plagued the micro-cap pharmaceutical company throughout FY26.

Read full news article

Alpa Laboratories Ltd is Rated Strong Sell

2026-02-08 10:10:17

Alpa Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 08 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

When is the next results date for Alpa Laboratories Ltd?

2026-01-30 23:20:17

The next results date for Alpa Laboratories Ltd is scheduled for 11 February 2026....

Read full news article

Alpa Laboratories Ltd is Rated Strong Sell

2026-01-28 10:10:20

Alpa Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 28 January 2026, providing investors with an up-to-date view of its performance and outlook.

Read full news article

Alpa Laboratories Ltd Falls to 52-Week Low of Rs.63.76 Amid Continued Downtrend

2026-01-21 11:29:21

Alpa Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a fresh 52-week low of Rs.63.76, marking a significant decline amid broader market pressures and company-specific performance issues.

Read full news article

Alpa Laboratories Ltd Falls to 52-Week Low of Rs.67.83

2026-01-20 11:39:11

Alpa Laboratories Ltd has declined to a fresh 52-week low of Rs.67.83, marking a significant downturn amid broader market fluctuations and company-specific performance issues. The stock’s recent slide reflects ongoing pressures in the Pharmaceuticals & Biotechnology sector, with the share price now trading well below all key moving averages.

Read full news article

Alpa Laboratories Ltd Falls to 52-Week Low of Rs.68.16 Amidst Continued Downtrend

2026-01-19 12:41:42

Alpa Laboratories Ltd’s stock declined sharply to a fresh 52-week low of Rs.68.16 on 19 Jan 2026, marking a significant drop amid ongoing challenges in both its long-term and recent financial performance. The stock’s fall comes despite a broadly stable market environment, with the Sensex closing down 0.66% but still near its 52-week high.

Read full news article

Alpa Laboratories Ltd is Rated Strong Sell

2026-01-05 10:11:38

Alpa Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 05 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

View All News